Ozempic raises healthcare costs, whether you can get it or not
About 165 million Americans rely on employer-sponsored health insurance, and yet workers still may not get the coverage they want,…
Diets to lose weight
These drugmakers are catching up to Eli Lilly and Novo Nordisk
The lucrative market for weight-loss drugs won’t be a duopoly forever. With billions at stake, that’s been a virtual guarantee…
Half of Workers May Have Difficulty Obtaining Obesity Drug Insurance Coverage
An injectable pen of Zepbound, Eli Lilly's weight loss drug, is on display in New York City on December 11,…
Nestlé CEO discusses impact of weight loss drugs on food industry
A photo taken on February 21, 2024 shows the logo of Swiss food giant Nestlé at the company's headquarters in…
WeightWatchers CEO Just Sent Memo to Employees as Stock Plunges
Sima Sistani, CEO, WW International, August 16, 2023. Scott Mlyn | CNBC WeightWatchers CEO Sima Sistani sent an internal memo…
Zepbound is off to a good start, but here's what Eli Lilly investors are watching
Hopes are sky-high for Eli Lilly's recently launched weight-loss drug Zepbound. Investors will tune into the company's fourth-quarter earnings conference…